{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0013093/OMIM:613029","label":"Glioma susceptibility 3","mondoId":"MONDO:0013093","onsetQualifier":null,"recordKeys":["1a7b5726d0f92b8a4e090d7f078ebd95f854c532c71f1dd108d3c68db0b09b5b","3043cda2f60b3e42305572fe4b9331dbd2dfdbae1a0dc7285ec6d3d7627cf686","38cbf9e93276d4ce2757439b0a7ec9219aeed1b4e995adea487d1f6329692cf2","59c8fdcd1a7fdcb7dfe769e573883303ee4a8fd4a9e969aab54f894dfea95d6e","7386b29074b691bd016a41224c8a5d3ac1b9e63c75da6b3a463a6a6180f5275c","a27686978c4d02c0857fecb68dcb47a11c238e61ce443f40b44340888edd0127","f23bc2b8e450fcea44d554479cd8db4de7a7ef92eedf05cae50b49fb23014e18"],"recordQualifiers":{},"scopeLabel":"OMIM:613029","sourceIds":["OMIM:613029"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0013093/OMIM:613029"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":7,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"omim":0,"orphanet":0,"published":7}},"features":[{"hpoId":"HP:0004808","label":"Acute myeloid leukemia","primary":false},{"hpoId":"HP:0009592","label":"Astrocytoma","primary":false},{"hpoId":"HP:0004812","label":"B Acute Lymphoblastic Leukemia","primary":false},{"hpoId":"HP:0012174","label":"Glioblastoma multiforme","primary":false},{"hpoId":"HP:0002885","label":"Medulloblastoma","primary":false},{"hpoId":"HP:0002667","label":"Nephroblastoma","primary":false},{"hpoId":"HP:0006727","label":"T-cell acute lymphoblastic leukemias","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0013093","records":[{"frequencyKind":"count","key":"1a7b5726d0f92b8a4e090d7f078ebd95f854c532c71f1dd108d3c68db0b09b5b","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"9/30","hpo_id":"HP:0002667","is_excluded":false,"label":"Nephroblastoma","onset_id":null,"reference":"PMID:16825431;PMID:15689453","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3043cda2f60b3e42305572fe4b9331dbd2dfdbae1a0dc7285ec6d3d7627cf686","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"3/28","hpo_id":"HP:0006727","is_excluded":false,"label":"T-cell acute lymphoblastic leukemias","onset_id":null,"reference":"PMID:16825431","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"38cbf9e93276d4ce2757439b0a7ec9219aeed1b4e995adea487d1f6329692cf2","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"2/30","hpo_id":"HP:0004812","is_excluded":false,"label":"B Acute Lymphoblastic Leukemia","onset_id":null,"reference":"PMID:16825431;PMID:15689453","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"59c8fdcd1a7fdcb7dfe769e573883303ee4a8fd4a9e969aab54f894dfea95d6e","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"10/28","hpo_id":"HP:0004808","is_excluded":false,"label":"Acute myeloid leukemia","onset_id":null,"reference":"PMID:16825431","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7386b29074b691bd016a41224c8a5d3ac1b9e63c75da6b3a463a6a6180f5275c","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"8/30","hpo_id":"HP:0002885","is_excluded":false,"label":"Medulloblastoma","onset_id":null,"reference":"PMID:16825431;PMID:15689453","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a27686978c4d02c0857fecb68dcb47a11c238e61ce443f40b44340888edd0127","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"2/28","hpo_id":"HP:0009592","is_excluded":false,"label":"Astrocytoma","onset_id":null,"reference":"PMID:16825431","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f23bc2b8e450fcea44d554479cd8db4de7a7ef92eedf05cae50b49fb23014e18","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0012174","is_excluded":false,"label":"Glioblastoma multiforme","onset_id":null,"reference":"PMID:15689453","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"glioma-susceptibility-3","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"glioma susceptibility 3"},"schemaVersion":1}